6.
  
    Townsley D, Scheinberg P, Winkler T, Desmond R, Dumitriu B, Rios O
    
    . Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia. N Engl J Med. 2017; 376(16):1540-1550.
          PMC: 5548296.
    
          DOI: 10.1056/NEJMoa1613878.
    
    
View
   
 
                                          
  7.
  
    Solomou E, Keyvanfar K, Young N
    
    . T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia. Blood. 2006; 107(10):3983-91.
          PMC: 1895294.
    
          DOI: 10.1182/blood-2005-10-4201.
    
    
View
   
 
                                          
  8.
  
    Wanachiwanawin W, Siripanyaphinyo U, Piyawattanasakul N, Kinoshita T
    
    . A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia. Eur J Haematol. 2006; 76(6):502-9.
    
          DOI: 10.1111/j.0902-4441.2005.t01-1-EJH2467.x.
    
    
View
   
 
                                          
  9.
  
    Calado R, Young N
    
    . Telomere diseases. N Engl J Med. 2009; 361(24):2353-65.
          PMC: 3401586.
    
          DOI: 10.1056/NEJMra0903373.
    
    
View
   
 
                                          
  10.
  
    Liu C, Zheng M, Wang T, Jiang H, Fu R, Wang H
    
    . PKM2 Is Required to Activate Myeloid Dendritic Cells from Patients with Severe Aplastic Anemia. Oxid Med Cell Longev. 2018; 2018:1364165.
          PMC: 5832124.
    
          DOI: 10.1155/2018/1364165.
    
    
View
   
 
                                          
  11.
  
    Zhang T, Yuan X, Liu C, Li Y, Liu H, Li L
    
    . Decreased TIM-3 expression of peripheral blood natural killer cells in patients with severe aplastic anemia. Cell Immunol. 2017; 318:17-22.
    
          DOI: 10.1016/j.cellimm.2017.03.003.
    
    
View
   
 
                                          
  12.
  
    Wang T, Mei S, Fu R, Wang H, Shao Z
    
    . Expression of Shelterin component POT1 is associated with decreased telomere length and immunity condition in humans with severe aplastic anemia. J Immunol Res. 2014; 2014:439530.
          PMC: 4033360.
    
          DOI: 10.1155/2014/439530.
    
    
View
   
 
                                          
  13.
  
    Afable 2nd M, Wlodarski M, Makishima H, Shaik M, Sekeres M, Tiu R
    
    . SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes. Blood. 2011; 117(25):6876-84.
          PMC: 3128479.
    
          DOI: 10.1182/blood-2010-11-314393.
    
    
View
   
 
                                          
  14.
  
    Ogawa S
    
    . Clonal hematopoiesis in acquired aplastic anemia. Blood. 2016; 128(3):337-47.
          PMC: 5054460.
    
          DOI: 10.1182/blood-2016-01-636381.
    
    
View
   
 
                                          
  15.
  
    Shallis R, Ahmad R, Zeidan A
    
    . Aplastic anemia: Etiology, molecular pathogenesis, and emerging concepts. Eur J Haematol. 2018; 101(6):711-720.
    
          DOI: 10.1111/ejh.13153.
    
    
View
   
 
                                          
  16.
  
    Park M, Park C, Cho Y, Jang S, Lee J, Lee J
    
    . Alterations in the bone marrow microenvironment may elicit defective hematopoiesis: a comparison of aplastic anemia, chronic myeloid leukemia, and normal bone marrow. Exp Hematol. 2016; 45:56-63.
    
          DOI: 10.1016/j.exphem.2016.09.009.
    
    
View
   
 
                                          
  17.
  
    Calado R, Young N
    
    . Telomere maintenance and human bone marrow failure. Blood. 2008; 111(9):4446-55.
          PMC: 2343587.
    
          DOI: 10.1182/blood-2007-08-019729.
    
    
View
   
 
                                          
  18.
  
    Dumitriu B, Feng X, Townsley D, Ueda Y, Yoshizato T, Calado R
    
    . Telomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia. Blood. 2014; 125(4):706-9.
          PMC: 4304114.
    
          DOI: 10.1182/blood-2014-10-607572.
    
    
View
   
 
                                          
  19.
  
    Solomou E, Gibellini F, Stewart B, Malide D, Berg M, Visconte V
    
    . Perforin gene mutations in patients with acquired aplastic anemia. Blood. 2007; 109(12):5234-7.
          PMC: 1890825.
    
          DOI: 10.1182/blood-2006-12-063495.
    
    
View
   
 
                                          
  20.
  
    Narita A, Muramatsu H, Okuno Y, Sekiya Y, Suzuki K, Hamada M
    
    . Development of clinical paroxysmal nocturnal haemoglobinuria in children with aplastic anaemia. Br J Haematol. 2017; 178(6):954-958.
    
          DOI: 10.1111/bjh.14790.
    
    
View